Pulmonology drugs

35 results

  • acthar

    (Repository Corticotropin)
    Mallinckrodt ARD LLC
    Acthar Gel is indicated for treating infantile spasms in infants under 2, acute exacerbations of multiple sclerosis in adults, and as adjunctive therapy for various rheumatic disorders. It is also used for certain collagen diseases, severe dermatologic and allergic conditions, ophthalmic inflammatory diseases, symptomatic sarcoidosis, and nephrotic syndrome.

  • adempas

    (riociguat)
    Bayer HealthCare Pharmaceuticals Inc.
    Adempas is indicated for adults with chronic thromboembolic pulmonary hypertension (CTEPH) after surgical treatment or if inoperable, as well as for pulmonary arterial hypertension (PAH). It improves exercise capacity, WHO functional class, and delays clinical worsening. The drug is effective as monotherapy or in combination with other treatments.

  • advair

    (fluticasone propionate and salmeterol)
    GlaxoSmithKline LLC
    ADVAIR DISKUS is indicated for the twice-daily treatment of asthma in patients aged 4 and older and for the maintenance treatment of chronic obstructive pulmonary disease (COPD). It is not intended for acute bronchospasm relief or for patients not adequately controlled on long-term asthma medications.

  • advair hfa

    (fluticasone propionate and salmeterol xinafoate)
    GlaxoSmithKline LLC
    ADVAIR HFA is indicated for the treatment of asthma in adults and adolescents aged 12 and older who are not adequately controlled on long-term asthma medications or require both an inhaled corticosteroid and a long-acting beta2-adrenergic agonist. It is not for acute bronchospasm relief.

  • albuked

    (Albumin (Human))
    KEDRION BIOPHARMA, INC.
    Albuked 25 is indicated for emergency treatment of hypovolemic shock, burn therapy, and as a treatment for hypoproteinemia, ARDS, acute liver failure, neonatal hemolytic disease, and acute nephrosis. It may also be used during cardiopulmonary bypass and renal dialysis to maintain blood volume and colloid osmotic pressure.

  • albuked

    (Albumin (Human))
    KEDRION BIOPHARMA, INC.
    Albuked 5 is indicated for the emergency treatment of hypovolemic shock, burn therapy, cardiopulmonary bypass, acute liver failure, and sequestration of protein-rich fluids. It aids in expanding circulating blood volume and maintaining colloid osmotic pressure in various clinical scenarios.

  • alvesco

    (ciclesonide)
    Covis Pharma US, Inc
    ALVESCO is indicated for the maintenance treatment of asthma in adults and pediatric patients aged 12 and older. It is not intended for the relief of acute bronchospasm or for children under 12 years of age.

  • anoro ellipta

    (umeclidinium bromide and vilanterol trifenatate)
    GlaxoSmithKline LLC
    ANORO ELLIPTA is indicated for the maintenance treatment of chronic obstructive pulmonary disease (COPD). It is not intended for the relief of acute bronchospasm or asthma treatment, and its safety and effectiveness in asthma have not been established.

  • arnuity ellipta

    (fluticasone furoate)
    GlaxoSmithKline LLC
    ARNUITY ELLIPTA is indicated for the maintenance treatment of asthma in adults and children aged 5 years and older, but is not intended for the relief of acute bronchospasm.

  • avycaz

    (ceftazidime, avibactam)
    Allergan, Inc.
    AVYCAZ (ceftazidime and avibactam) is indicated for treating complicated intra-abdominal and urinary tract infections, including pyelonephritis, as well as hospital-acquired and ventilator-associated bacterial pneumonia. It targets susceptible gram-negative bacteria in adult and pediatric patients (≥31 weeks gestational age).